Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir Superboosting in HIV/TB Co-infected Children
NCT02348177Phase 4Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ritonavir in human immunodeficiency virus infection (HIV), sponsored by Drugs for Neglected Diseases initiative. Primary endpoint: Modelled C0/morning trough. Started Jan 2013; status: completed.
02
Drugs
ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02348177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348177.